Ye L - Search Results

1

Research progress in tumor targeted immunotherapy.

Fang Y, Yu A, Ye L, Zhai G. Fang Y, et al. Among authors: ye l. Expert Opin Drug Deliv. 2021 Aug;18(8):1067-1090. doi: 10.1080/17425247.2021.1882992. Epub 2021 Apr 14. Expert Opin Drug Deliv. 2021. PMID: 33507117 Review.

2

Photo-triggered self-destructive ROS-responsive nanoparticles of high paclitaxel/chlorin e6 co-loading capacity for synergetic chemo-photodynamic therapy.

Yang X, Shi X, Zhang Y, Xu J, Ji J, Ye L, Yi F, Zhai G. Yang X, et al. Among authors: ye l. J Control Release. 2020 Jul 10;323:333-349. doi: 10.1016/j.jconrel.2020.04.027. Epub 2020 Apr 20. J Control Release. 2020. PMID: 32325174

3

Research Progress in Bioinspired Drug Delivery Systems.

Tong Q, Qiu N, Ji J, Ye L, Zhai G. Tong Q, et al. Among authors: ye l. Expert Opin Drug Deliv. 2020 Sep;17(9):1269-1288. doi: 10.1080/17425247.2020.1783235. Epub 2020 Jun 25. Expert Opin Drug Deliv. 2020. PMID: 32543953 Review.

4

A molybdenum oxide-based degradable nanosheet for combined chemo-photothermal therapy to improve tumor immunosuppression and suppress distant tumors and lung metastases.

Qiu N, Yang X, Zhang Y, Zhang J, Ji J, Zhang Y, Kong X, Xi Y, Liu D, Ye L, Zhai G. Qiu N, et al. Among authors: ye l. J Nanobiotechnology. 2021 Dec 19;19(1):428. doi: 10.1186/s12951-021-01162-2. J Nanobiotechnology. 2021. PMID: 34923976 Free PMC article.

5

A ROS-responsive biomimetic nano-platform for enhanced chemo-photodynamic-immunotherapy efficacy.

Yan H, Zhang Y, Zhang Y, Li Y, Kong X, Liu D, Li J, Xi Y, Ji J, Ye L, Zhai G. Yan H, et al. Among authors: ye l. Biomater Sci. 2022 Nov 8;10(22):6583-6600. doi: 10.1039/d2bm01291j. Biomater Sci. 2022. PMID: 36227002

6

Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer.

Wu H, Du X, Xu J, Kong X, Li Y, Liu D, Yang X, Ye L, Ji J, Xi Y, Zhai G. Wu H, et al. Among authors: ye l. Acta Biomater. 2023 Feb;157:551-565. doi: 10.1016/j.actbio.2022.12.010. Epub 2022 Dec 10. Acta Biomater. 2023. PMID: 36513248

7

Salt sensitive purely zwitterionic physical hydrogel for prevention of postoperative tissue adhesion.

Fang Y, Huang S, Gong X, King JA, Wang Y, Zhang J, Yang X, Wang Q, Zhang Y, Zhai G, Ye L. Fang Y, et al. Among authors: ye l. Acta Biomater. 2023 Mar 1;158:239-251. doi: 10.1016/j.actbio.2022.12.045. Epub 2022 Dec 27. Acta Biomater. 2023. PMID: 36581005

8

A Vanadium-Based Nanoplatform Synergizing Ferroptotic-like Therapy with Glucose Metabolism Intervention for Enhanced Cancer Cell Death and Antitumor Immunity.

Zhang Y, Du X, He Z, Gao S, Ye L, Ji J, Yang X, Zhai G. Zhang Y, et al. Among authors: ye l. ACS Nano. 2023 Jun 27;17(12):11537-11556. doi: 10.1021/acsnano.3c01527. Epub 2023 Jun 5. ACS Nano. 2023. PMID: 37272777

9

A dual-sensitive nanoparticle-mediated deepening synergistic therapy strategy involving DNA damage and ICD stimuli to treat triple-negative breast cancer.

Liu S, Kong X, Fang Y, He Z, Wu H, Ji J, Yang X, Ye L, Zhai G. Liu S, et al. Among authors: ye l. Biomater Sci. 2023 Sep 12;11(18):6325-6341. doi: 10.1039/d3bm00781b. Biomater Sci. 2023. PMID: 37555273

10

Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy.

Fang Y, Huang S, Hu Q, Zhang J, King JA, Wang Y, Wei Z, Lu J, He Z, Kong X, Yang X, Ji J, Li J, Zhai G, Ye L. Fang Y, et al. Among authors: ye l. ACS Nano. 2023 Dec 26;17(24):24883-24900. doi: 10.1021/acsnano.3c05898. Epub 2023 Oct 26. ACS Nano. 2023. PMID: 37883579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,623 results

Search Page

Filters